- Home
- A-Z Publications
- Current Pharmaceutical Design
- Previous Issues
- Volume 25, Issue 5, 2019
Current Pharmaceutical Design - Volume 25, Issue 5, 2019
Volume 25, Issue 5, 2019
-
-
Women’s Beliefs About Medicines and Adherence to Pharmacotherapy in Pregnancy: Opportunities for Community Pharmacists
Background: During pregnancy, women might weigh the benefits of treatment against potential risks to the unborn child. However, non-adherence to necessary treatment can adversely affect both mother and child. To optimize pregnant women’s beliefs and medication adherence, community pharmacists are ideally positioned to play an important role in primary care. Objective: This narrative review aimed to summarize the ev Read More
-
-
-
Clinical Pharmacokinetic Studies in Pregnant Women and the Relevance of Pharmacometric Tools
Authors: André Dallmann, Paola Mian, Johannes V. den Anker and Karel AllegaertBackground: In clinical pharmacokinetic (PK) studies, pregnant women are significantly underrepresented because of ethical and legal reasons which lead to a paucity of information on potential PK changes in this population. As a consequence, pharmacometric tools became instrumental to explore and quantify the impact of PK changes during pregnancy. Methods: We explore and discuss the typical characteristics of populat Read More
-
-
-
Methodological Approaches to Evaluate Fetal Drug Exposure
Authors: Naïm Bouazza, Frantz Foissac, Déborah Hirt, Saïk Urien, Sihem Benaboud, Gabrielle Lui and Jean-Marc TreluyerBackground: Drug prescriptions are usual during pregnancy, however, women and their fetuses still remain an orphan population with regard to drugs efficacy and safety. Most xenobiotics diffuse through the placenta and some of them can alter fetus development resulting in structural abnormalities, growth or functional deficiencies. Methods: To summarize the different methodologies developed towards the prediction Read More
-
-
-
Human Placental Vascular Reactivity in Health and Disease: Implications for the Treatment of Pre-eclampsia
Adequate development of the placenta is essential for optimal pregnancy outcome. Pre-eclampsia (PE) is increasingly recognized to be a consequence of placental dysfunction and can cause serious maternal and fetal complications during pregnancy. Furthermore, PE increases the risk of neonatal problems and has been shown to be a risk factor for cardiovascular disease of the mother later in life. Currently, there is no Read More
-
-
-
Emerging Research Paradigm for Infant Drug Exposure Through Breast Milk
By Shinya ItoBackground: Information on drug secretion into milk is insufficient due to the exclusion of lactating women from clinical trials and drug development processes. As a result, non-adherence to the necessary drug therapy and discontinuation of breastfeeding occur, even if the predicted level of infant exposure is low. In contrast, inadvertent infant exposure to drugs in breast milk continues to happen due to lack Read More
-
-
-
Non-clinical Models to Determine Drug Passage into Human Breast Milk
Authors: Domenico Ventrella, Monica Forni, Maria L. Bacci and Pieter AnnaertBackground: Successful practice of clinical perinatal pharmacology requires a thorough understanding of the pronounced physiological changes during lactation and how these changes affect various drug disposition processes. In addition, pharmacokinetic processes unique to lactation have remained understudied. Hence, determination of drug disposition mechanisms in lactating women and their babies remains a domain wi Read More
-
-
-
Next Generation Medical Management of Postpartum Hemorrhage
Authors: Jaclyn M. Phillips, John N. van den Anker and Homa K. AhmadziaBackground: Postpartum hemorrhage remains a significant contributor to morbidity and mortality of women of childbearing age worldwide. Trends in both incidence and severity of postpartum hemorrhage are increasing which makes it imperative to identify drugs that could target prevention and/or treatment of these postpartum hemorrhages for women living in high, middle and low-income countries. Methods: We have revie Read More
-
-
-
Pharmacokinetics, Placental and Breast Milk Transfer of Antiretroviral Drugs in Pregnant and Lactating Women Living with HIV
Authors: E.M. Hodel, C. Marzolini, C. Waitt and N. RakhmaninaBackground: Remarkable progress has been achieved in the identification of HIV infection in pregnant women and in the prevention of vertical HIV transmission through maternal antiretroviral treatment (ART) and neonatal antiretroviral drug (ARV) prophylaxis in the last two decades. Millions of women globally are receiving combination ART throughout pregnancy and breastfeeding, periods associated with significant biological a Read More
-
-
-
Safety and Efficacy of Tocolytics for the Treatment of Spontaneous Preterm Labour
Authors: Ronald F. Lamont and Jan S. JørgensenBackground: Preterm birth is the major cause of perinatal mortality and morbidity worldwide. Attempts to reduce the burden may be proactive using biochemical or biophysical prediction and preventative measures. If these efforts fail, then the approach may have to be reactive using tocolytics to inhibit spontaneous preterm labour. Objective: We have reviewed the evidence concerning the safety and efficacy of variou Read More
-
-
-
Antenatal Corticosteroids for Fetal Lung Maturity - Too Much of a Good Thing?
Authors: Lenka Hrabalkova, Tsukasa Takahashi, Matthew W. Kemp and Sarah J. StockBackground: Between 5-15% of babies are born prematurely worldwide, with preterm birth defined as delivery before 37 completed weeks of pregnancy (term is at 40 weeks of gestation). Women at risk of preterm birth receive antenatal corticosteroids as part of standard care to accelerate fetal lung maturation and thus improve neonatal outcomes in the event of delivery. As a consequence of this treatment, the Read More
-
-
-
Sildenafil for Antenatal Treatment of Congenital Diaphragmatic Hernia: From Bench to Bedside
Authors: Francesca M. Russo, Felix De Bie, Ryan Hodges, Alan Flake and Jan DeprestBackground: Persistent pulmonary hypertension (PPH) is one of the main causes of mortality and morbidity in infants affected by congenital diaphragmatic hernia (CDH). Since the structural changes that lead to PPH take place already in utero, a treatment starting in the prenatal phase may prevent the occurrence of this complication. Objective: To summarize the development process of antenatal sildenafil for CDH. Met Read More
-
-
-
Collaboration in Regulatory Science to Facilitate Therapeutic Development for Pregnant Women
Authors: Catherine Roca, Leyla Sahin and Lynne YaoBackground: Therapeutic tragedies of the past, ethical concerns, and legal risks, among other factors have led to a conservative approach to clinical research during pregnancy, resulting in a de facto exclusion of pregnant women from most clinical therapeutics trials. As a result, there is a deficit of knowledge regarding the safety and proper dosing of medications during pregnancy, leaving prescribers with limited informati Read More
-
-
-
Mobile Health Applications for Prenatal Assessment and Monitoring
Authors: Wilfried Gyselaers, Dorien Lanssens, Helen Perry and Asma KhalilBackground: A mobile health application is an exciting, fast-paced domain that is likely to improve prenatal care. Methods: In this narrative review, we summarise the use of mobile health applications in this setting with a special emphasis on both the benefits of remote monitoring devices and the potential pitfalls of their use, highlighting the need for robust regulations and guidelines before their widespread introduction into pr Read More
-
Volumes & issues
-
Volume 31 (2025)
-
Volume 30 (2024)
-
Volume 29 (2023)
-
Volume 28 (2022)
-
Volume 27 (2021)
-
Volume 26 (2020)
-
Volume 25 (2019)
- Issue 46
- Issue 45
- Issue 44
- Issue 43
- Issue 42
- Issue 41
- Issue 40
- Issue 39
- Issue 38
- Issue 37
- Issue 36
- Issue 35
- Issue 34
- Issue 33
- Issue 32
- Issue 31
- Issue 30
- Issue 29
- Issue 28
- Issue 27
- Issue 26
- Issue 25
- Issue 24
- Issue 23
- Issue 22
- Issue 21
- Issue 20
- Issue 19
- Issue 18
- Issue 17
- Issue 16
- Issue 15
- Issue 14
- Issue 13
- Issue 12
- Issue 11
- Issue 10
- Issue 9
- Issue 8
- Issue 7
- Issue 6
- Issue 5
- Issue 4
- Issue 3
- Issue 2
- Issue 1
-
Volume 24 (2018)
-
Volume 23 (2017)
-
Volume 22 (2016)
-
Volume 21 (2015)
-
Volume 20 (2014)
-
Volume 19 (2013)
-
Volume 18 (2012)
-
Volume 17 (2011)
-
Volume 16 (2010)
-
Volume 15 (2009)
-
Volume 14 (2008)
-
Volume 13 (2007)
-
Volume 12 (2006)
-
Volume 11 (2005)
-
Volume 10 (2004)
-
Volume 9 (2003)
-
Volume 8 (2002)
-
Volume 7 (2001)
-
Volume 6 (2000)
Most Read This Month
Article
content/journals/cpd
Journal
10
5
false
en
